Clinical trial
A Longitudinal Study Assessing the Infectious Status and Immunity of Mothers and Their Children in Lambaréné, Including Intermittent Treatment of Children With Sulfadoxine-pyrimethamine for Malaria Control and Its Impact on Long-term Health
NCT00167843 is registered in ClinicalTrials.gov with Albert Schweitzer Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Longitudinal Study Assessing the Infectious Status and Immunity of Mothers and Their Children in Lambaréné, Including Intermittent Treatment of Children With Sulfadoxine-pyrimethamine for Malaria Control and Its Impact on Long-term Health
- Lead sponsor
- Albert Schweitzer Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2002
- Completion date
- March 31, 2007
- Enrollment
- 1,189
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.